Showing results (21-30 of 194) with videos related to
Sort By:
Pageof 20
Clinical Pharmacokinetics|November 4, 2019
Clinical Pharmacokinetics and Pharmacodynamics of Etravirine: An Updated ReviewJoshua P Havens, Anthony T Podany, Kimberly K Scarsi, et al.Pharmacogenetics and Genomics|February 17, 2025
Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosisNia Covington, Anne F Luetkemeyer, Marjorie Z Imperial, et al.Journal of the American Board of Family Medicine : JABFM|October 24, 2007
Clinical utility of interferon gamma assay in the diagnosis of tuberculosisMiguel G Madariaga, Ziba Jalali, Susan SwindellsCurrent Opinion in HIV and AIDS|November 6, 2018
Creating demand for long-acting formulations for the treatment and prevention of HIV, tuberculosis, and viral hepatitisCharles Flexner, David L Thomas, Susan SwindellsThe American Journal of Medicine|October 1, 2008
Extensively drug-resistant tuberculosisMiguel G Madariaga, Umesh G Lalloo, Susan SwindellsInternational Journal of Antimicrobial Agents|November 9, 2020
Long-acting drugs and formulations for the treatment and prevention of HIV infectionCharles Flexner, Andrew Owen, Marco Siccardi, et al.Antiviral Therapy|March 27, 2009
Simplification strategies to reduce antiretroviral drug exposure: progress and prospectsJohn E McKinnon, John W Mellors, Susan SwindellsJournal of the International Association of Providers of AIDS Care|September 3, 2021
A Midwestern Academic HIV Clinic Operation during the COVID-19 Pandemic: Implementation Strategy and Preliminary OutcomesNada Fadul, Nichole Regan, Layan Kaddoura, et al.AIDS and Behavior|February 16, 2006
HIV education needs among Sudanese immigrants and refugees in the Midwestern United StatesMarc Tompkins, Lynette Smith, Katherine Jones, et al.Nanomedicine (London, England)|February 21, 2014
Interview: Nanomedicine and the fight against HIV/AIDSAndré Nel, Susan Swindells, Tatiana Bronich, et al.Pageof 20